[HTML][HTML] Molecular and translational classifications of DAMPs in immunogenic cell death
AD Garg, L Galluzzi, L Apetoh, T Baert… - Frontiers in …, 2015 - frontiersin.org
The immunogenicity of malignant cells has recently been acknowledged as a critical
determinant of efficacy in cancer therapy. Thus, besides developing direct …
determinant of efficacy in cancer therapy. Thus, besides developing direct …
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.
AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge… - Frontiers in …, 2015 - sonar.ch
English The immunogenicity of malignant cells has recently been acknowledged as a critical
determinant of efficacy in cancer therapy. Thus, besides developing direct …
determinant of efficacy in cancer therapy. Thus, besides developing direct …
[PDF][PDF] Molecular and translational Classifications of DaMPs in immunogenic Cell Death
RB Birge12, JM Bravo-San Pedro… - Frontiers in …, 2015 - helda.helsinki.fi
Augmenting the immunogenicity of cancer cells to improve the efficacy of cancer therapy is a
paradigm that has gained significant momentum over the past 5 years (1–5). Researchers …
paradigm that has gained significant momentum over the past 5 years (1–5). Researchers …
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
AD Garg, L Galluzzi, L Apetoh… - Frontiers in …, 2015 - scholarship.libraries.rutgers.edu
The immunogenicity of malignant cells has recently been acknowledged as a critical
determinant of efficacy in cancer therapy. Thus, besides developing direct …
determinant of efficacy in cancer therapy. Thus, besides developing direct …
Molecular and translational classifications of DAMPs in immunogenic cell death
AD Garg, L Galluzzi, L Apetoh, T Baert… - FRONTIERS IN …, 2015 - iris.unito.it
The immunogenicity of malignant cells has recently been acknowledged as a critical
determinant of efficacy in cancer therapy. Thus, besides developing direct …
determinant of efficacy in cancer therapy. Thus, besides developing direct …
[PDF][PDF] Molecular and translational Classifications of DaMPs in immunogenic Cell Death
RB Birge12, JM Bravo-San Pedro… - Frontiers in …, 2015 - academia.edu
Augmenting the immunogenicity of cancer cells to improve the efficacy of cancer therapy is a
paradigm that has gained significant momentum over the past 5 years (1–5). Researchers …
paradigm that has gained significant momentum over the past 5 years (1–5). Researchers …
[PDF][PDF] Molecular and translational Classifications of DaMPs in immunogenic Cell Death
RB Birge12, JM Bravo-San Pedro… - Frontiers in …, 2015 - researchgate.net
Augmenting the immunogenicity of cancer cells to improve the efficacy of cancer therapy is a
paradigm that has gained significant momentum over the past 5 years (1–5). Researchers …
paradigm that has gained significant momentum over the past 5 years (1–5). Researchers …
[PDF][PDF] Molecular and translational Classifications of DaMPs in immunogenic Cell Death
RB Birge12, JM Bravo-San Pedro, K Breckpot13… - Frontiers in …, 2015 - core.ac.uk
Augmenting the immunogenicity of cancer cells to improve the efficacy of cancer therapy is a
paradigm that has gained significant momentum over the past 5 years (1–5). Researchers …
paradigm that has gained significant momentum over the past 5 years (1–5). Researchers …
[引用][C] Molecular and translational classifications of DAMPs in immunogenic cell death
AD Garg, L Galluzzi, L Apetoh… - Frontiers in …, 2015 - produccioncientifica.ucm.es
[PDF][PDF] Molecular and translational Classifications of DaMPs in immunogenic Cell Death
RB Birge12, JM Bravo-San Pedro… - Frontiers in …, 2015 - lirias.kuleuven.be
Augmenting the immunogenicity of cancer cells to improve the efficacy of cancer therapy is a
paradigm that has gained significant momentum over the past 5 years (1–5). Researchers …
paradigm that has gained significant momentum over the past 5 years (1–5). Researchers …
